Overview
Sollis Health, based in New York, United States, has raised $33M in a Series B round on Dec 2, 2024, with participation from Investor 89. The company headline 28. The round will be used to accelerate product development, expand the team, and scale go-to-market operations.
Operating in the industry 28 sector, Sollis Health is positioned to capitalize on growing demand for innovative solutions in this space. The company was founded in 0 by Brad Olson. Brad brings deep domain expertise and a track record of execution that attracted investor confidence in this round. With fresh capital, the company is expected to invest heavily in R&D and talent acquisition, signaling a period of aggressive growth ahead.
Market Outlook
With $33M now on the balance sheet, Sollis Health enters a new phase of growth that typically involves rapid hiring, technology upgrades, and vendor evaluations. For sales professionals and service providers, this represents a prime opportunity to engage while budget allocation decisions are being made and the team is actively building out its operational infrastructure.
Why contact Sollis Health now
With $33M in fresh capital from Series B, Sollis Health is entering a rapid growth phase. Post-funding startups typically increase headcount by 30-50% and begin evaluating new tools and services immediately. The founders and decision-makers are actively taking meetings right now — making this the perfect time to connect before their calendars fill up.
Founders & Contacts
Investors
Company Facts
| Company | Sollis Health |
| Amount Raised | $33M |
| Funding Round | Series B |
| Date Raised | Dec 2, 2024 |
| Founded | 0 |
| Industry | Industry 28 |
| Founders | Brad Olson |
| HQ Location | New York, United States |
Get Verified Founder Emails
Access verified email addresses and contact details for Sollis Health's founders and thousands of other funded startups.
Start Free Trial